Yang Y - Search Results

1

Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma.

Li F, Xu Y, Deng P, Yang Y, Sui W, Jin F, Hao M, Li Z, Zang M, Zhou D, Gu Z, Ru K, Wang J, Cheng T, Qiu L. Li F, et al. Among authors: yang y. Oncotarget. 2015 Apr 20;6(11):9434-44. doi: 10.18632/oncotarget.3319. Oncotarget. 2015. PMID: 25831238 Free PMC article. Clinical Trial.

2

RARα2 expression confers myeloma stem cell features.

Yang Y, Shi J, Tolomelli G, Xu H, Xia J, Wang H, Zhou W, Zhou Y, Das S, Gu Z, Levasseur D, Zhan F, Tricot G. Yang Y, et al. Blood. 2013 Aug 22;122(8):1437-47. doi: 10.1182/blood-2013-02-482919. Epub 2013 Jul 11. Blood. 2013. PMID: 23847194 Free PMC article.

3

A subset of CD20(+) MM patients without the t(11;14) are associated with poor prognosis and a link to aberrant expression of Wnt signaling.

Liu J, Gu Z, Yang Y, Wendlandt E, Xu H. Liu J, et al. Among authors: yang y. Hematol Oncol. 2014 Dec;32(4):215-7. doi: 10.1002/hon.2120. Epub 2014 Jan 9. Hematol Oncol. 2014. PMID: 24408089 Free PMC article. No abstract available.

4

Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.

Hao M, Zang M, Wendlandt E, Xu Y, An G, Gong D, Li F, Qi F, Zhang Y, Yang Y, Zhan F, Qiu L. Hao M, et al. Among authors: yang y. Int J Cancer. 2015 Apr 15;136(8):1835-44. doi: 10.1002/ijc.29199. Epub 2014 Sep 19. Int J Cancer. 2015. PMID: 25220540 Free PMC article.

5

NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma.

Yang Y, Zhou W, Xia J, Gu Z, Wendlandt E, Zhan X, Janz S, Tricot G, Zhan F. Yang Y, et al. Oncotarget. 2014 Dec 15;5(23):11986-97. doi: 10.18632/oncotarget.2388. Oncotarget. 2014. PMID: 25230277 Free PMC article.

6

Nek2 is a novel regulator of B cell development and immunological response.

Gu Z, Zhou W, Huang J, Yang Y, Wendlandt E, Xu H, He X, Tricot G, Zhan F. Gu Z, et al. Among authors: yang y. Biomed Res Int. 2014;2014:621082. doi: 10.1155/2014/621082. Epub 2014 Nov 17. Biomed Res Int. 2014. PMID: 25485281 Free PMC article.

7

Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma.

Yang Y, Shi J, Gu Z, Salama ME, Das S, Wendlandt E, Xu H, Huang J, Tao Y, Hao M, Franqui R, Levasseur D, Janz S, Tricot G, Zhan F. Yang Y, et al. Cancer Res. 2015 Feb 1;75(3):594-604. doi: 10.1158/0008-5472.CAN-14-2362. Epub 2015 Jan 14. Cancer Res. 2015. PMID: 25589346 Free PMC article.

8

Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).

Li P, Huang P, Yang Y, Hao M, Peng H, Li F. Li P, et al. Among authors: yang y. Clin Rev Allergy Immunol. 2016 Feb;50(1):55-63. doi: 10.1007/s12016-015-8466-y. Clin Rev Allergy Immunol. 2016. PMID: 25663566 Review.

9

BUB1B promotes multiple myeloma cell proliferation through CDC20/CCNB axis.

Yang Y, Gu C, Luo C, Li F, Wang M. Yang Y, et al. Med Oncol. 2015 Mar;32(3):81. doi: 10.1007/s12032-015-0542-x. Epub 2015 Feb 20. Med Oncol. 2015. PMID: 25698537

10

Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China.

Li F, Yang Y, Jin F, Dehoedt C, Rao J, Zhou Y, Li P, Yang G, Wang M, Zhang R, Yang Y. Li F, et al. Among authors: yang g, yang y. Orphanet J Rare Dis. 2015 Feb 15;10:20. doi: 10.1186/s13023-015-0224-y. Orphanet J Rare Dis. 2015. PMID: 25757854 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108,724 results

Search Page

Filters